CollPlant Biotechnologies Ltd.
CLGN
$2.71
$0.083.04%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -3.35M | -3.88M | -4.21M | -4.20M | |
| Total Depreciation and Amortization | 229.00K | 242.00K | 261.00K | 280.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 272.00K | 354.00K | 612.00K | 415.00K | |
| Change in Net Operating Assets | 406.00K | -182.00K | -591.00K | 247.00K | |
| Cash from Operations | -2.44M | -3.46M | -3.93M | -3.25M | |
| Capital Expenditure | -3.00K | -59.00K | -202.00K | -82.00K | |
| Sale of Property, Plant, and Equipment | 0.00 | 1.00K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 0.00 | -57.00K | -- | |
| Cash from Investing | -3.00K | -58.00K | -259.00K | -82.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 3.10M | 0.00 | 0.00 | 9.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 3.10M | 0.00 | 0.00 | 9.00K | |
| Foreign Exchange rate Adjustments | 40.00K | 60.00K | -118.00K | -123.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 699.00K | -3.46M | -4.31M | -3.45M | |